BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16127037)

  • 1. Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.
    Nouér SA; Nucci M; de-Oliveira MP; Pellegrino FL; Moreira BM
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3663-7. PubMed ID: 16127037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant Pseudomonas aeruginosa infections pose growing threat to health care-associated infection control in the hospitals of Southern China: a case-control surveillance study.
    Peng Y; Bi J; Shi J; Li Y; Ye X; Chen X; Yao Z
    Am J Infect Control; 2014 Dec; 42(12):1308-11. PubMed ID: 25444305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
    Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
    J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis.
    Matos ECO; Andriolo RB; Rodrigues YC; Lima PDL; Carneiro ICDRS; Lima KVB
    Rev Soc Bras Med Trop; 2018; 51(4):415-420. PubMed ID: 30133622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
    Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
    J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the multifactor dimensionality reduction method in evaluation of the roles of multiple genes/enzymes in multidrug-resistant acquisition in Pseudomonas aeruginosa strains.
    Yao Z; Peng Y; Bi J; Xie C; Chen X; Li Y; Ye X; Zhou J
    Epidemiol Infect; 2016 Mar; 144(4):856-63. PubMed ID: 26234343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
    Obritsch MD; Fish DN; MacLaren R; Jung R
    Pharmacotherapy; 2005 Oct; 25(10):1353-64. PubMed ID: 16185180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of metallo β-lactamase producing multidrug resistant Pseudomonas aeruginosa from various clinical samples.
    Ramakrishnan K; Rajagopalan S; Nair S; Kenchappa P; Chandrakesan SD
    Indian J Pathol Microbiol; 2014; 57(4):579-82. PubMed ID: 25308010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
    Martins AF; Zavascki AP; Gaspareto PB; Barth AL
    Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-beta-lactamase in a hospital located in Rio de Janeiro, Brazil.
    Carvalho AP; Albano RM; de Oliveira DN; Cidade DA; Teixeira LM; Marques Ede A
    Microb Drug Resist; 2006; 12(2):103-8. PubMed ID: 16922625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals.
    Zavascki AP; Barth AL; Gaspareto PB; Gonçalves AL; Moro AL; Fernandes JF; Goldani LZ
    J Antimicrob Chemother; 2006 Oct; 58(4):882-5. PubMed ID: 16895936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
    Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
    Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa epidemic strain carrying bla(SPM) metallo-beta-lactamase detected in Rio de Janeiro, Brazil.
    Pellegrino FL; Casali N; Dos Santos KR; Nouér SA; Scheidegger EM; Riley LW; Moreira BM
    J Chemother; 2006 Apr; 18(2):151-6. PubMed ID: 16736883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity.
    Paramythiotou E; Lucet JC; Timsit JF; Vanjak D; Paugam-Burtz C; Trouillet JL; Belloc S; Kassis N; Karabinis A; Andremont A
    Clin Infect Dis; 2004 Mar; 38(5):670-7. PubMed ID: 14986251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full characterization of the integrative and conjugative element carrying the metallo-β-lactamase bla SPM-1 and bicyclomycin bcr1 resistance genes found in the pandemic Pseudomonas aeruginosa clone SP/ST277.
    Fonseca EL; Marin MA; Encinas F; Vicente AC
    J Antimicrob Chemother; 2015 Sep; 70(9):2547-50. PubMed ID: 26093374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
    Zavascki AP; Barth AL; Gonçalves AL; Moro AL; Fernandes JF; Martins AF; Ramos F; Goldani LZ
    J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital.
    Cezário RC; Duarte De Morais L; Ferreira JC; Costa-Pinto RM; da Costa Darini AL; Gontijo-Filho PP
    Enferm Infecc Microbiol Clin; 2009 May; 27(5):269-74. PubMed ID: 19386392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of multidrug resistant pseudomonas aeruginosa infection and the relationship with type III secretion system in patients with diabetic foot.
    Zhang J; Chu Y; Wang P; Ji X; Li X; Wang C; Peng Y
    Int J Low Extrem Wounds; 2014 Sep; 13(3):205-10. PubMed ID: 25106442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
    Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.